EDWARDS LAUNCHES THE SAPIEN 3 ULTRA RESILIA VALVE IN EUROPE WITH TECHNOLOGY TO ENHANCE DURABILITY
NYON, Switzerland–(BUSINESS WIRE)– Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.* Edwards’ SAPIEN 3 Ultra RESILIA valve recently received CE Mark† for use in patients with heart valve disease […]